Logo image of MRK

MERCK & CO. INC. (MRK) Stock Overview

USA - NYSE:MRK - US58933Y1055 - Common Stock

86.32 USD
+1.53 (+1.8%)
Last: 10/20/2025, 8:04:00 PM
86.5 USD
+0.18 (+0.21%)
After Hours: 10/20/2025, 8:04:00 PM

MRK Key Statistics, Chart & Performance

Key Statistics
Market Cap215.61B
Revenue(TTM)63.62B
Net Income(TTM)16.41B
Shares2.50B
Float2.50B
52 Week High105.11
52 Week Low73.31
Yearly Dividend3.1
Dividend Yield3.86%
EPS(TTM)7.7
PE11.21
Fwd PE8.87
Earnings (Next)10-30 2025-10-30/bmo
IPO1941-01-01
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


MRK short term performance overview.The bars show the price performance of MRK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 6

MRK long term performance overview.The bars show the price performance of MRK in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15

The current stock price of MRK is 86.32 USD. In the past month the price increased by 7.36%. In the past year, price decreased by -16.98%.

MERCK & CO. INC. / MRK Daily stock chart

MRK Latest News, Press Relases and Analysis

MRK Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 50.09 765.65B
JNJ JOHNSON & JOHNSON 18.66 466.54B
AZN ASTRAZENECA PLC-SPONS ADR 18.89 260.04B
NVS NOVARTIS AG-SPONSORED ADR 14.89 255.13B
NVO NOVO-NORDISK A/S-SPONS ADR 14.29 247.68B
PFE PFIZER INC 7.28 140.38B
SNY SANOFI-ADR 11.23 121.19B
GSK GSK PLC-SPON ADR 9.8 88.74B
BMY BRISTOL-MYERS SQUIBB CO 6.48 88.72B
ZTS ZOETIS INC 23.32 64.29B
TAK TAKEDA PHARMACEUTIC-SP ADR 48.55 44.47B
HLN HALEON PLC-ADR 19.2 41.90B

About MRK

Company Profile

MRK logo image Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The company is headquartered in Rahway, New Jersey and currently employs 75,000 full-time employees. Its Pharmaceutical segment includes human health pharmaceutical and vaccine products. The firm sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The company sells these human health vaccines primarily to physicians, wholesalers, distributors and government entities. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its products include KEYTRUDA (pembrolizumab) injection, for intravenous use; WELIREG (belzutifan) tablets, for oral use; Ohtuvayre (ensifentrine) and others.

Company Info

MERCK & CO. INC.

126 East Lincoln Avenue, P.O. Box 2000

Rahway NEW JERSEY 07033 US

CEO: Kenneth C. Frazier

Employees: 75000

MRK Company Website

MRK Investor Relations

Phone: 19087404000

MERCK & CO. INC. / MRK FAQ

What is the stock price of MERCK & CO. INC. today?

The current stock price of MRK is 86.32 USD. The price increased by 1.8% in the last trading session.


What is the ticker symbol for MERCK & CO. INC. stock?

The exchange symbol of MERCK & CO. INC. is MRK and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is MRK stock listed?

MRK stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for MERCK & CO. INC. stock?

33 analysts have analysed MRK and the average price target is 101.49 USD. This implies a price increase of 17.58% is expected in the next year compared to the current price of 86.32. Check the MERCK & CO. INC. stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MERCK & CO. INC. worth?

MERCK & CO. INC. (MRK) has a market capitalization of 215.61B USD. This makes MRK a Mega Cap stock.


How many employees does MERCK & CO. INC. have?

MERCK & CO. INC. (MRK) currently has 75000 employees.


What are the support and resistance levels for MERCK & CO. INC. (MRK) stock?

MERCK & CO. INC. (MRK) has a support level at 85.7 and a resistance level at 87.57. Check the full technical report for a detailed analysis of MRK support and resistance levels.


Is MERCK & CO. INC. (MRK) expected to grow?

The Revenue of MERCK & CO. INC. (MRK) is expected to grow by 1.09% in the next year. Check the estimates tab for more information on the MRK EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MERCK & CO. INC. (MRK) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MERCK & CO. INC. (MRK) stock pay dividends?

MERCK & CO. INC. (MRK) has a dividend yield of 3.86%. The yearly dividend amount is currently 3.1. Check the full fundamental report for a detailed analysis of MRK dividend history, reliability and sustainability.


When does MERCK & CO. INC. (MRK) report earnings?

MERCK & CO. INC. (MRK) will report earnings on 2025-10-30, before the market open.


What is the Price/Earnings (PE) ratio of MERCK & CO. INC. (MRK)?

The PE ratio for MERCK & CO. INC. (MRK) is 11.21. This is based on the reported non-GAAP earnings per share of 7.7 and the current share price of 86.32 USD. Check the full fundamental report for a full analysis of the valuation metrics for MRK.


What is the Short Interest ratio of MERCK & CO. INC. (MRK) stock?

The outstanding short interest for MERCK & CO. INC. (MRK) is 1.11% of its float. Check the ownership tab for more information on the MRK short interest.


MRK Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to MRK. When comparing the yearly performance of all stocks, MRK is a bad performer in the overall market: 78% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

MRK Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to MRK. MRK has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MRK Financial Highlights

Over the last trailing twelve months MRK reported a non-GAAP Earnings per Share(EPS) of 7.7. The EPS increased by 18.28% compared to the year before.


Industry RankSector Rank
PM (TTM) 25.79%
ROA 13.96%
ROE 33.49%
Debt/Equity 0.69
Chartmill High Growth Momentum
EPS Q2Q%-3.95%
Sales Q2Q%-1.9%
EPS 1Y (TTM)18.28%
Revenue 1Y (TTM)1.82%

MRK Forecast & Estimates

33 analysts have analysed MRK and the average price target is 101.49 USD. This implies a price increase of 17.58% is expected in the next year compared to the current price of 86.32.

For the next year, analysts expect an EPS growth of 17.93% and a revenue growth 1.09% for MRK


Analysts
Analysts75.76
Price Target101.49 (17.57%)
EPS Next Y17.93%
Revenue Next Year1.09%

MRK Ownership

Ownership
Inst Owners80.53%
Ins Owners0.05%
Short Float %1.11%
Short Ratio2.28